Background Posterior circulation ischemic vertigo (PCIV) can often be used as a precursor symptom of cerebral infarction. It has the characteristics of recurrent attacks, lingering and non healing, which seriously affects the quality of life of patients. However, the clinical efficacy of conventional western medicine treatment is limited. At present, traditional Chinese patent medicines and simple preparations injection has significant efficacy in controlling and alleviating the onset of vertigo. However, in view of the wide variety of traditional Chinese patent medicines and simple preparations preparations, there is a lack of relevant evidence-based medical evidence to evaluate the advantages and disadvantages of various traditional Chinese patent medicines and simple preparations injections.
Objective To evaluate the efficacy and safety of different Chinese herbal injections combined with conventional western drugs in the treatment of PCIV using reticulated Meta-analysis.
Methods A comprehensive search was conducted on CNKI, Wanfang Data, VIP, SinoMed, PubMed, Embase, Web of Science, and Cochrane Library up to May 7, 2024, for randomized controlled trials involving TCM injections for the treatment of PCIV. Randomized controlled trial (RCT) on the treatment of post-circulatory ischemic dizziness with herbal injections. The Cochrane risk of bias tool was used to evaluate the quality of the included literature, and RevMan 5.4 and Stata 17 software were used for data analysis.
Results Forty-nine RCT with 4 556 patients were finally included, involving 13 types of traditional Chinese medicine injections, including Danshen Chuanxiongqin injection, Danhong injection, Shenxiong Putaotang injection, Shenmai injection, Tianmasu injection, Dengzhanhuasu injection, Shuxuetong injection, Honghuahuangsesu injection, Shuxuening injection, Kudiezi injection, Gegensu injection, Xingnaojing injection, Yinxingdamo injection. Net Meta-analysis showed that in terms of vertigo symptom improvement[i.e. Dizziness Disorder Inventory (DHI) score]: the top 3 SUCRA-ranked interventions were Xingnaojing injection (87.2%) , Shenmai injection (73.5%) , and Shuxuening injection (59.6%) in combination with conventional western medicine, respectively; In terms of total clinical effectiveness: the top 3 SUCRA-ranked interventions were Yinxingdamo injection (88.3%) , Tianmasu injection (63.3%) , and Gegensu injection (57.6%) in combination with conventional western medicines, respectively; In terms of improvement of blood flow velocity in left and right vertebral arteries: the top three interventions were Xingnaojing injection (96.2%, 99.2%) , Dengzhanhuasu injection (90.2%, 85.6%) , and Honghuahuangsesu injection (69.3%, 79.4%) in combination with conventional western medicines; In terms of improvement of blood flow velocity in basilar arteries: the top three interventions were Dengzhanhuasu injection (97.6%) , Honghuahuangsesu injection (85.8%) , and Xingnaojing injection (80.6%) in combination with conventional western medicine; In terms of the improvement of whole blood high cut viscosity, the top three interventions were Shenmai injection (85.6%) , Danhong injection (80.0%) , and Shuxuetong injection (77.5%) in combination with conventional western drugs, respectively; In terms of the improvement of whole blood low cut viscosity, the top three interventions were Shuxuetong injection (90.3%) , Tianmasu injection (77.5%) , and Shenmai injection (73.0%) in combination with conventional western drugs, respectively. In terms of safety: no serious adverse drug reactions occurred in all studies.
Conclusion Xingnaojing injection combined with conventional western medicine showed excellent clinical efficacy in improving PCIV vertigo symptoms and vertebral basilar artery blood flow velocity, which provided a certain reference for clinical medication, and the combination of traditional Chinese patent medicines and simple preparations injection and conventional western medicine was superior to conventional western medicine alone, and had good drug safety. However, the available evidence is limited by the quality and quantity of the included literature, and the above conclusions need to be further validated by more high-quality prospective RCT.